
About Fosun Pharmaceutical
Fosun Pharmaceutical is a publicly listed company based in Shanghai (China) founded in 1994. Research, development, production, and sale of pharmaceuticals are provided. The company has 40,560 employees. Fosun Pharmaceutical has completed 3 acquisitions, including Antejin Biotech, Breas Medical and Yiyanyun Medical Technology. Its website fosunpharma.com draws about 22 thousand monthly visits. Fosun Pharmaceutical offers products and services including Pharmaceuticals and Medical Devices. Its focus areas include Traditional Pharmaceuticals, Generics, Therapeutic Areas and Traditional Medical Devices. Its legal entity is Shanghai Fuxing Medicine (Group) Shareholding Company Limited.
Company details
Fosun Pharmaceutical was founded in 1994 in Shanghai, China, where operations in the pharmaceutical sector are centered. Research, development, production, and sales of pharmaceuticals are conducted globally. In 2021, annual revenues of 6.03B were achieved, alongside a net profit of 0.73B. The company is headquartered in Shanghai and maintains a presence in the healthcare industry through its core activities.
- Headquarters Shanghai, China
- Employees 40,560
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website fosunpharma.com
- Social LinkedIn
- Legal Name Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A
- Annual Revenue$5.93 B (USD)1.44as on Dec 31, 2025
- Net Profit$481.36 M (USD)21.69as on Dec 31, 2025
- EBITDA$871.3 M (USD)5.51as on Dec 31, 2025
- Employee Count40,560
- Investments & AcquisitionsAntejin Biotech
& 2 more
Products & Services of Fosun Pharmaceutical
Fosun Pharmaceutical offers a comprehensive portfolio of products and services, including Pharmaceuticals and Medical Devices.
Pharmaceuticals are developed and manufactured for various treatments, focusing on patient needs and clinical demands.
Medical devices and diagnostics are produced and supplied for health services, including tools for diagnosis and treatment.
IPO & Listings of Fosun Pharmaceutical
Fosun Pharmaceutical is a publicly listed company on the SSE with ticker symbol 600196 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Oct 2012
- Listed onHKG: 2196
- Listed entityShanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE000000X38
- Share price23.27 CNY (-1.02% on the day) · 2026-10-14
- Market capitalisation57,994,469,363.72 CNY
- Price to earnings18.1
- EPS (diluted, trailing year)1.28 CNY
- Dividend yield1.65%
- Volume (last session)13,536,766
Financials of Fosun Pharmaceutical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 41.50B CNY | 3.37B CNY | 6.10B CNY |
| 2024 | 40.92B CNY | 2.77B CNY | 5.78B CNY |
| 2023 | 41.25B CNY | 2.39B CNY | 3.96B CNY |
| 2022 | 43.82B CNY | 3.73B CNY | 5.57B CNY |
| 2021 | 38.87B CNY | 4.73B CNY | 4.20B CNY |
Detailed financial statements for Fosun Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fosun Pharmaceutical
Fosun Pharmaceutical has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Antejin Biotech, Breas Medical and Yiyanyun Medical Technology.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Bacterial vaccine development and pharmaceutical services are provided. | Chengdu, China | 0 | Nov 2021 | β’β’β’β’ | ||
Software solutions for pharmacy R&D management are provided. | epharmacloud.com | Minhang, China | 2018 | Sep 2020 | $665,316 | |
Sleep therapy and home care ventilation devices | breas.com | Gothenburg, Sweden | 1991 | Mar 2017 | β’β’β’β’ |
Complete acquisition details for Fosun Pharmaceutical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Fosun Pharmaceutical
5 dated milestones of Fosun Pharmaceutical across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Fosun Pharmaceutical is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Breas Medical.
- Acquisition Acquires Yiyanyun Medical Technology.
- Acquisition Acquires Antejin Biotech.
Web traffic of Fosun Pharmaceutical
The website of Fosun Pharmaceutical (fosunpharma.com) receives about 21.9K visits a month.
- Monthly visits21.9K
▼ 25.1% vs previous month
Websites whose visitors overlap most with Fosun Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
tigermed.net | tigermed.net | 100% | β | ||
| henlius.com | 97% | 25K | #1,127,187 | View details | |
bioton.pl | bioton.pl | 91% | β | ||
| mijian360.com | 62% | 13.7K | #1,976,732 | View details | |
| ubipharm.com | 54% | 680.7K | #908,789 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 8 similar websites and full traffic analytics for Fosun Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fosun Pharmaceutical
Complete news archive for Fosun Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fosun Pharmaceutical
Fosun Pharmaceutical was founded in 1994.
Fosun Pharmaceutical is headquartered in Shanghai, China.
Fosun Pharmaceutical has 40,560 employees.
Annual revenue of Fosun Pharmaceutical is $5.93B as on Dec 31, 2025.
Fosun Pharmaceutical was founded in 1994 in Shanghai, China, where operations in the pharmaceutical sector are centered. Research, development, production, and sales of pharmaceuticals are conducted globally. In 2021, annual revenues of 6.03B were achieved, alongside a net profit of 0.73B. The company is headquartered in Shanghai and maintains a presence in the healthcare industry through its core activities.
Fosun Pharmaceutical offers Pharmaceuticals and Medical Devices.
Yes, Fosun Pharmaceutical is publicly traded on SSE under the ticker symbol 600196.
Fosun Pharmaceutical has made 3 acquisitions, including Antejin Biotech, Breas Medical, and Yiyanyun Medical Technology.
Fosun Pharmaceutical operates through Shanghai Fuxing Medicine (Group) Shareholding Company Limited.
